Steward Partners Investment Advisory’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $242K | Sell |
6,728
-934
| -12% | -$33.7K | ﹤0.01% | 1663 |
|
|
2025
Q1 | $239K | Buy |
7,662
+3,231
| +73% | +$101K | ﹤0.01% | 1567 |
|
|
2024
Q4 | $113K | Buy |
4,431
+3,942
| +806% | +$101K | ﹤0.01% | 1917 |
|
|
2024
Q3 | $13.8K | Buy |
489
+84
| +21% | +$2.38K | ﹤0.01% | 2819 |
|
|
2024
Q2 | $10.7K | Buy |
405
+3
| +0.7% | +$79 | ﹤0.01% | 2799 |
|
|
2024
Q1 | $12.2K | Buy |
402
+211
| +110% | +$6.41K | ﹤0.01% | 2732 |
|
|
2023
Q4 | $5.36K | Buy |
191
+2
| +1% | +$56 | ﹤0.01% | 2934 |
|
|
2023
Q3 | $5.14K | Buy |
189
+1
| +0.5% | +$27 | ﹤0.01% | 2812 |
|
|
2023
Q2 | $5.78K | Sell |
188
-24
| -11% | -$738 | ﹤0.01% | 2748 |
|
|
2023
Q1 | $7.64K | Buy |
212
+21
| +11% | +$757 | ﹤0.01% | 2642 |
|
|
2022
Q4 | $7.54K | Buy |
191
+6
| +3% | +$237 | ﹤0.01% | 2625 |
|
|
2022
Q3 | $7K | Hold |
185
| – | – | ﹤0.01% | 2662 |
|
|
2022
Q2 | $8K | Hold |
185
| – | – | ﹤0.01% | 2606 |
|
|
2022
Q1 | $7K | Hold |
185
| – | – | ﹤0.01% | 2791 |
|
|
2021
Q4 | $7K | Buy |
+185
| New | +$7K | ﹤0.01% | 2735 |
|